---
title: "Revvity Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293669264.md"
description: "Revvity Inc. (RVTY) shares rose 2.38% to $113.17 on Thursday, marking its third consecutive day of gains despite a broader market decline. The stock underperformed relative to competitors like Danaher and Agilent Technologies but outperformed IDEXX Laboratories. Trading volume exceeded the 50-day average. Revvity remains 4.34% below its 52-week high."
datetime: "2026-07-23T21:14:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293669264.md)
  - [en](https://longbridge.com/en/news/293669264.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293669264.md)
generator: "portal-rs"
---

# Revvity Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Revvity Inc. (RVTY) rose 2.38% to $113.17 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.

This was the stock's third consecutive day of gains.

Revvity Inc. closed 4.34% below its 52-week high of $118.30, which the company reached on January 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Danaher Corp. (DHR) rose 7.46% to $192.50, IDEXX Laboratories Inc. (IDXX) fell 1.03% to $539.37, and Agilent Technologies Inc. (A) rose 4.71% to $139.74.

Trading volume (1.5 M) eclipsed its 50-day average volume of 1.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-23-26 1714ET

### Related Stocks

- [RVTY.US](https://longbridge.com/en/quote/RVTY.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)
- [IDXX.US](https://longbridge.com/en/quote/IDXX.US.md)
- [A.US](https://longbridge.com/en/quote/A.US.md)

## Related News & Research

- [Revvity agrees to acquire Human Cell Design in metabolic disease research push](https://longbridge.com/en/news/298435704.md)
- [Revvity Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/297233641.md)
- [Revvity Inc. Stock Outperforms Competitors Despite Losses On The Day](https://longbridge.com/en/news/297700031.md)
- [Arrowstreet Capital Limited Partnership Sells 328,169 Shares of Revvity Inc. $RVTY](https://longbridge.com/en/news/295068635.md)
- [RVTY: Diagnostics drove double-digit growth and margin gains, offsetting Life Sciences softness](https://longbridge.com/en/news/294803062.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**